WASHINGTON – Democrats’ landslide victory within the midterm elections could have vital implications for the upcoming negotiations over a key funding supply for the Meals and Drug Administration, partially by empowering a significant critic of this system.
The FDA collects person charges from pharmaceutical firms to fund the company’s evaluations of their medicines. The Prescription Person Payment Drug Act have to be renewed earlier than the present legislation expires on Sept. 30. In any other case, it may disrupt the FDA’s potential to approve medicines.
The facility to form that laws will fall to senior Democrats, together with Sen. Bernie Sanders (I-Vt.), who will possible lead the Senate’s well being committee. Sanders is likely one of the few lawmakers who’ve opposed the core premise of the person price construction.
This text is unique to STAT+ subscribers
Unlock this text — plus day by day intelligence on Capitol Hill and the life sciences trade — by subscribing to STAT+.
Have already got an account? Log in
View All Plans

